Jihong Cui
Affiliations: | Albert Einstein College of Medicine, New York, New York, United States |
Area:
mammary stem cell and breast cancer stem cellGoogle:
"Jihong Cui"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Michael Detmar | grad student | 2011-2015 | ETH Zürich |
| Wenjun Guo | post-doc | 2016- |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cui J, Christin JR, Reisz JA, et al. (2023) Targeting ABCA12-controlled ceramide homeostasis inhibits breast cancer stem cell function and chemoresistance. Science Advances. 9: eadh1891 |
| Liu Y, John P, Nishitani K, et al. (2023) A SOX9-B7x axis safeguards dedifferentiated tumor cells from immune surveillance to drive breast cancer progression. Developmental Cell |
| Cui J, Zhang C, Lee JE, et al. (2023) MLL3 loss drives metastasis by promoting a hybrid epithelial-mesenchymal transition state. Nature Cell Biology |
| Cui J, Guo W. (2021) Establishment and long-term culture of mouse mammary stem cell organoids and breast tumor organoids. Star Protocols. 2: 100577 |
| Jia L, Zhang J, Ma T, et al. (2018) The Function of Fucosylation in Progression of Lung Cancer. Frontiers in Oncology. 8: 565 |
| Hodge DQ, Cui J, Gamble MJ, et al. (2018) Histone Variant MacroH2A1 Plays an Isoform-Specific Role in Suppressing Epithelial-Mesenchymal Transition. Scientific Reports. 8: 841 |
| Cui J, Xie X. (2017) Non-coding RNAs: emerging regulatory factors in the derivation and differentiation of mammalian parthenogenetic embryonic stem cells. Cell Biology International |
| Liu W, Yin L, Yan X, et al. (2017) Directing the Differentiation of Parthenogenetic Stem Cells into Tenocytes for Tissue-Engineered Tendon Regeneration. Stem Cells Translational Medicine. 6: 196-208 |
| Cui J, Hollmén M, Li L, et al. (2016) New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate. Oncotarget |
| Rao Y, Cui J, Yin L, et al. (2016) Preclinical study of mouse pluripotent parthenogenetic embryonic stem cell derivatives for the construction of tissue-engineered skin equivalent. Stem Cell Research & Therapy. 7: 156 |